Literature DB >> 18258982

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

Marina Parton1, Ian E Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258982     DOI: 10.1200/JCO.2007.14.3016

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Is Chemoendocrine Treatment without Alternative?

Authors:  Richard Greil
Journal:  Breast Care (Basel)       Date:  2008-08-22       Impact factor: 2.860

Review 2.  CYP2D6 and tamoxifen: DNA matters in breast cancer.

Authors:  Janelle M Hoskins; Lisa A Carey; Howard L McLeod
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

Review 3.  Genotype-guided tamoxifen therapy: time to pause for reflection?

Authors:  Timothy L Lash; Ernst A Lien; Henrik Toft Sørensen; Stephen Hamilton-Dutoit
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

4.  Pharmacoeconomic considerations in the treatment of breast cancer.

Authors:  Athanasios Pallis; Vasiliki Tsiantou; Efi Simou; Nikos Maniadakis
Journal:  Clinicoecon Outcomes Res       Date:  2010-06-15

Review 5.  Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.

Authors:  Pamela Taxel; Erika Faircloth; Sana Idrees; Catherine Van Poznak
Journal:  J Endocr Soc       Date:  2018-05-21

6.  An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

Authors:  S Verma; S Sehdev; A Joy; Y Madarnas; J Younus; J A Roy
Journal:  Curr Oncol       Date:  2009-07       Impact factor: 3.677

7.  Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide.

Authors:  Jennifer Gjerde; Sara Gandini; Aliana Guerrieri-Gonzaga; Line L Haugan Moi; Valentina Aristarco; Gunnar Mellgren; Andrea Decensi; Ernst A Lien
Journal:  Breast Cancer Res Treat       Date:  2012-05-05       Impact factor: 4.872

8.  Tamoxifen Initiation After Ductal Carcinoma In Situ.

Authors:  Hazel B Nichols; Erin J A Bowles; Jessica Islam; Lawrence Madziwa; Til Stürmer; Diem-Thy Tran; Diana S M Buist
Journal:  Oncologist       Date:  2016-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.